Patients and healthy controls
| No. . | Age, y/sex . | Diagnosis . | Chromosomal analysis . |
|---|---|---|---|
| 1 | 38/F | Healthy control | ND |
| 2 | 37/M | Healthy control | ND |
| 3 | 41/F | Healthy control | ND |
| 4 | 41/M | Healthy control | ND |
| 5 | 42/M | Healthy control | ND |
| 6 | 48/M | Healthy control | ND |
| 7 | 42/M | Healthy control | ND |
| 8 | 78/M | Healthy control | ND |
| 9 | 58/M | RARS | 46XY |
| 10 | 77/M | RAEB | 46XY |
| 11 | 61/M | RA | 46XY, 11q− |
| 12 | 42/F | RA | 46XX, t(1:13) |
| 13 | 56/M | RAEB | 46XY |
| 14 | 62/M | RARS | 46XY |
| 15 | 60/M | RA | 46XY, 20q− |
| 16 | 64/M | RA | 47XY, +8 |
| 17 | 64/M | RAEB | 46XY, 20q− |
| 18 | 65/M | RARS | 46XY |
| No. . | Age, y/sex . | Diagnosis . | Chromosomal analysis . |
|---|---|---|---|
| 1 | 38/F | Healthy control | ND |
| 2 | 37/M | Healthy control | ND |
| 3 | 41/F | Healthy control | ND |
| 4 | 41/M | Healthy control | ND |
| 5 | 42/M | Healthy control | ND |
| 6 | 48/M | Healthy control | ND |
| 7 | 42/M | Healthy control | ND |
| 8 | 78/M | Healthy control | ND |
| 9 | 58/M | RARS | 46XY |
| 10 | 77/M | RAEB | 46XY |
| 11 | 61/M | RA | 46XY, 11q− |
| 12 | 42/F | RA | 46XX, t(1:13) |
| 13 | 56/M | RAEB | 46XY |
| 14 | 62/M | RARS | 46XY |
| 15 | 60/M | RA | 46XY, 20q− |
| 16 | 64/M | RA | 47XY, +8 |
| 17 | 64/M | RAEB | 46XY, 20q− |
| 18 | 65/M | RARS | 46XY |
M indicates male; F, female; ND, not done; RA, refractory anemia; RARS, refractory anemia with ring sideroblast; and RAEB, refractory anemia with excess blast.